DMRA

Damora TherapeuticsD

Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences

At close

2026-07-20

View Chart

Peers tracked

U.S. public peers

Grade Position

Below peers

vs peer average

DMRA vs peer average

40/100

DMRA vs. peer average (D vs. C)

Grade spread

B 3 · C 2 · D 5 · F 1

Graded peers loaded

Coverage

11 graded

100% of tracked

Peer overview

RNXT is the first available peer comparator.

RenovoRx is a useful loose comparator for small-cap biotech milestone sensitivity and financing risk, though it is not a direct mechanism peer.

✓Peer source comes from the stored AI memo or peer model

✓Grades and factor rows use RankAlpha API data when available

✓Missing peer scores remain blank instead of being estimated

✓Side-by-side comparison keeps the data contract visible

Top peerRNXTRenovoRx

DMRA

Damora Therapeutics

RNXT

RenovoRx

Grade

Momentum

Value

Sentiment

Setup Bias

Net —

Market Cap

Posture

Defensive

Open Side-by-Side Comparison Compare all

Grade position vs RNXT

DMRA / RNXT

Grade Position

Below peers

DMRA vs. peer average (D vs. C)

40/100

Momentum

DMRA

Value

DMRA

Sentiment

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank

Ticker

Company

Grade

Grade score

vs DMRA

RNXT

40/100

Even

OTLK

20/100

CING

60/100

-1

ADMA

ADMA Biologics Inc Common

40/100

Even

VRDN

Viridian Therapeutics Inc Common

80/100

-2

RNXT is the first peer returned for this comparison set.